EzHomeo product walkthrough

Product comparison

EzHomeo vs Homeo AI: rubric review or dosage proposals?

EzHomeo keeps potency and dosage decisions with the practitioner; compare that boundary against Homeo AI’s broader proposed outputs.

By the EzHomeo editorial team at Omnoryx Technologies Pvt LtdPublished Reviewed

Evaluating EzHomeo? Start a reviewable consultation in the app. 10 consultation credits free, no card required.

Published by EzHomeo. We make one of the products compared.

EzHomeo keeps dosage and prescription decisions with the practitioner

EzHomeo’s published workflow starts with practitioner-controlled recording, a mixed-language transcript for review and rubrics the practitioner can edit before repertorisation across Kent, Synthesis, Complete, Murphy, Repertorium Publicum, Phatak and Boericke. It explicitly leaves prescription and dosage decisions to the practitioner. EzHomeo lists 10 starter consultation credits without a card, ₹999/month and ₹29,999 lifetime.

To examine that review boundary, start a synthetic EzHomeo case and edit every rubric before repertorisation.

Decision mapPut practitioner approval between proposal and use
Software proposalRanking · potency · dosage
Practitioner reviewInspect source and meaningCorrect or reject
Decision remains humanA proposal is not approval.
Homeo AI advertises outputs including potency and dosage proposals. This diagram marks the practitioner review required when evaluating those outputs.

Where Homeo AI may suit you better

Homeo AI’s home page describes dropping in a recorded patient conversation and receiving rubric-backed remedy rankings, and its FAQ says it also proposes potency and dosage guidance. It advertises photo-based analysis, an Android app and, on Premium, case exports. It names Kent, Murphy, Phatak, Choudhary, Clarke and Boericke, claims “50+” repertories, and says case taking works in English, Hindi and major international languages. That is a broader proposed-output set than EzHomeo offers today.

Its Indian pricing shows Starter at ₹19,990/year (₹1,999/month) and Premium at ₹29,990/year (₹2,999/month), with a three-day trial for first-time users that its FAQ says needs no credit card.

Read policy text rather than a badge

On 14 October 2026 Homeo AI’s privacy and terms pages showed a general information overview rather than policy wording, while its FAQ says patient data is encrypted in transit and at rest, enterprise customers can choose on-premise deployment and no data is used for AI training without explicit consent. EzHomeo publishes a versioned Privacy Policy and Terms.

Homeo AI’s pages do not name a legal operator or say whether listed prices include tax.

Homeo AI (homeo-ai.com) is a trademark of its owner. EzHomeo is not affiliated with or endorsed by Homeo AI.

Review lensAsk the demo to expose who controls the output
Proposed output
InspectWhere did it come from?Correct / rejectCan the practitioner change it?AttributeWho made the final decision?
Request a demonstration of correction, rejection and attribution.

Check the boundary in a real case

Try EzHomeo’s review workflow to review a transcript and rubrics, then request a Homeo AI demonstration of dosage review.

Related reading

Compare EzHomeo with CuraSim for a broader classical-repertory and clinic-suite shelf, see the ranked top 10 homeopathy software list, or return to resources.

FAQ

EzHomeo vs Homeo AI: frequently asked questions

EzHomeo transcribes the consultation and keeps every rubric, repertory choice and prescription decision with the practitioner. Homeo AI’s case intake accepts a recorded patient conversation and ranks remedies with the rubrics behind them, but its FAQ says it also proposes potency and dosage guidance.
If you want software that proposes a dosage alongside a remedy ranking, or need photo input and case exports, test Homeo AI alongside EzHomeo. If you want the final potency and dosage decision to stay entirely with you, test EzHomeo’s documented review controls first; both offer a no-card trial.
EzHomeo lists 10 starter consultation credits without a card, ₹999 per month, and ₹29,999 one-time for lifetime access. Homeo AI’s Indian pricing (checked 14 October 2026) lists Starter at ₹1,999/month or ₹19,990/year and Premium at ₹2,999/month or ₹29,990/year, with a three-day trial for first-time users that its FAQ says needs no card.
EzHomeo publishes a versioned Privacy Policy and Terms and Conditions. On 14 October 2026 Homeo AI’s privacy and terms pages showed general information text rather than policy wording, although its FAQ describes encryption and on-premise options for enterprise customers.

Sources

  • Homeo AI home page, FAQ and pricing section (browser-rendered)
  • Homeo AI download, privacy and terms pages
  • EzHomeo pricing (live app billing API) and EzHomeo’s own pages